We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




State-of-the-Art Software Controls New Microscope Imagining System

By LabMedica International staff writers
Posted on 25 Aug 2011
Two bioscience companies have combined their expertise to create a high performance imaging system particularly suitable for cellular analysis studies.

Leica Microsystems (Wetzlar, Germany) and Molecular Devices (Sunnyvale, CA, USA) have announced the launch of their new Leica MM AF NX imaging system. More...
This system brings together Leica Microsystems’ leading microscopy technology and Molecular Devices’ latest MetaMorph NX Software.

MetaMorph Software provides all the tools needed to perform meaningful analysis of images acquired by the Leica microscope. Common tools for thresholding, filtering, and feature extraction are included as well as other more sophisticated tools such as the integrated morphometry analysis (IMA) module. IMA allows objects to be measured and separated into user-definable classes, based on any combination of measured morphometric parameters, such as shape, size, or optical density. A point-and-click interface, linking images and spreadsheet results, makes it easy to choose representative objects for classification and measurement. All displayed images can be zoomed, paned, or scaled to any bit depth and colors can be assigned to channels for further investigation. Furthermore, the system automatically saves acquired images as well as measurement results, which can be accessed, reconfigured, and filtered at any time.

“The new Leica MM AF NX extends our offering of user-friendly and workflow-oriented imaging platforms like the Leica LAS AF software for sophisticated fluorescence applications,” said Sebastian Tille, head of the business segment at Leica Microsystems. “This evidences the fruitful collaboration between Molecular Devices and Leica Microsystems, in which the strengths of both companies complement one another.”

Related Links:
Leica Microsystems
Molecular Devices




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Electrolyte Analyzer
BKE-B
New
Gold Member
Quantitative lmmunoassay Test Menu
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers identified 157 metabolites linked to BBB damage, including 25 that appeared in at least two independent studies (Image Credit: Adobe Stock)

Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury

Early injury to the blood-brain barrier (BBB) can precede many neurological disorders but remains difficult to detect noninvasively. Laboratory markers that identify barrier dysfunction before symptoms... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.